ライフサイエンスコーパス: patients with

1 Patients with 1 or more previous admissions to an urban traum

2 Most patients with acquired TTP respond to a combination of plasma

3 ve identified the presence of bursitis in more than half of patients with active disease.

4 Five eligible studies including 4360 patients with acute ICH were pooled in meta-analysis.

5 stablish the effect of MABp1 with a new primary endpoint in patients with advanced colorectal cancer.

6 ning curve of the use of imatinib, in a large population of patients with advanced GIST.

7 ognostic significance of CNA presence in disease relapse in patients with AML.

8 Results Between diabetic patients with and diabetic patients without DPN, mean age (60

9 n multivariate analysis, patients with irregular Z line and patients with BE of >/= 1 cm did not differ significantly in

10 imal, and small distal airway brushings were collected from patients with BOS (n = 10), stable lung transplant patients (

11 iomarkers and development of treatment solutions to benefit patients with breast cancer at high risk of recurrence.

12 Antifungal treatment is indicated in almost all patients with chronic cavitary pulmonary infections, chronic

13 The proportion of patients with documented well-controlled asthma in this study

14 Individual data from 2092 patients with enteric fever randomized into 4 trials in Kathm

15 In conclusion, we demonstrate a relevant number of patients with FDG-PET false-negative MM and a strong associat

16 Patients with first-episode psychosis had lower regional FA i

17 osts, and resulting budget impact between ECHO and non-ECHO patients with HCV were then compared.

18 ciated with chronic inflammatory diseases, such as COPD, in patients with hemoptysis, TAE of the BAA and of the pathologi

19 ted allele burden, and ruxolitinib might extend survival of patients with higher-risk myelofibrosis.

20 Available data suggests that double mutations in patients with hypertrophic cardiomyopathy are not rare and ar

21 Based on this cutoff, 36.2% of patients with IBD in mucosal healing have increased intestina

22 y molecules are increased in inflamed intestinal tissues of patients with IBD.

23 The overall response rate for patients with IMT (treated at 100, 165, and 280 mg/m(2)/dose)

24 received training by allergists to offer BLAST for eligible patients with infectious diseases receiving nonpreferred ther

25 On multivariate analysis, patients with irregular Z line and patients with BE of >/= 1

26 Patients with lung or colorectal cancer often exhibit leukocy

27 zes during posturing and progresses during interruptions in patients with macula-on RD.

28 We apply ichorCNA to 1439 blood samples from 520 patients with metastatic prostate or breast cancers.

29 17 patients with MS and 11 healthy controls (HCs) underwent 3 ex

30 choosing an anti-VEGF drug for the hundreds of thousands of patients with nAMD treated each year worldwide.

31 ndomyocardial biopsies and blood samples were obtained from patients with newly diagnosed cardiomyopathy and clinical sus

32 A stratified random sample of 863 patients with newly diagnosed SCC of the oral cavity, orophar

33 on (FDA) as a stroke prevention alternative to warfarin for patients with nonvalvular atrial fibrillation.

34 ement of hepatitis B virus (HBV) e antigen-positive viremic patients with normal liver function and the incorporation of

35 e Examination [MMSE] </=25) using data from nine cohorts of patients with Parkinson's disease from North America and Euro

36 ml (P=0.03), above the 90th percentile for the 5-mg dose in patients with preserved renal function.

37 We examined the proportion of patients with prevalent ESRD in each facility referred for tr

38 Up to 70% of patients with primary biliary cholangitis develop pruritus (i

39 All patients with probable IA were repeatedly positive for both t

40 essed in reactive cholangiocytes, in both murine models and patients with PSC.

41 Patients with psoriasis have an increased risk of myocardial

42 Novel therapies are needed for patients with relapsed or refractory multiple myeloma (MM).

43 Patients with relapsing-remitting MS (RRMS) or clinically iso

44 Patients with repetitive ventricular tachycardia/ventricular

45 st adequate dosing of antibiotics to improve the outcome of patients with sepsis.

46 Patients with severe extracranial injuries (AIS >/= 3), death

47 MARS was used to support patients with severe liver trauma (SLT), in ALF patients as a

48 Decreased SST-IR neurons in the amygdala of patients with SZ and BD, interpreted here as decreased SST ex

49 s at target and major adverse cardiovascular outcomes among patients with T1DM.

50 Patients with testing ordered for C. difficile were enrolled